HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma
- PMID: 19040293
- PMCID: PMC2596973
- DOI: 10.1002/jmv.21322
HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma
Erratum in
- J Med Virol. 2009 Jun;81(6):1128. Athanasia, Tourlaki [corrected to Tourlaki, Athanasia]
Abstract
The link between human herpesvirus 8 (KSHV) and Kaposi's sarcoma (KS) has been proven, but many important aspects including risk factors, genetic predisposition to tumor development, transmission of KSHV, and the pathogenic potential of different genotypes remain to be elucidated. Possible associations between clinical parameters and antibody levels, viral load fluctuations, and viral genotype were analyzed by quantitative real-time PCR, an in-house developed IFA assay, and sequence analysis of ORF K1-VR1 in blood, serum and saliva of 38 subjects with classic KS (cKS). KSHV lytic antibodies were significantly increased in stage IV compared to stage I and II patients (p = 0.006 and p = 0.041, respectively). KSHV blood, serum, and saliva viral load was comparable in all stages. The highest viral loads were detected in saliva, and they decreased in stages III-IV compared to stages I-II patients. Higher concentrations of lytic antibodies and higher viral loads were observed in fast progressing cKS patients, in whom KSHV detection from blood was also more frequent. Type A KSHV strain was almost exclusively present in rapid progressors (12/17 cases), while C type was mainly present in slow progressing patients (6/7 cases). Finally, detection of type A KSHV strain associated with higher blood viral loads. KSHV lytic antibody levels and viral load can be used to monitor clinical evolution of cKS. Infection supported by KSHV A subtype is associated with more rapid progressive disease. Careful monitoring and aggressive therapeutic protocols should be considered in patients with KSHV A-supported infection.
Figures


Similar articles
-
Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients.J Gen Virol. 2011 Apr;92(Pt 4):744-51. doi: 10.1099/vir.0.027847-0. Epub 2011 Jan 7. J Gen Virol. 2011. PMID: 21216985
-
Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.Int J Cancer. 2019 Nov 1;145(9):2468-2477. doi: 10.1002/ijc.32546. Epub 2019 Jul 18. Int J Cancer. 2019. PMID: 31265124
-
Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations.J Gen Virol. 2004 Jan;85(Pt 1):155-163. doi: 10.1099/vir.0.19465-0. J Gen Virol. 2004. PMID: 14718630
-
Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8: a new virus in human pathology.J Am Acad Dermatol. 1997 Jul;37(1):107-13. doi: 10.1016/s0190-9622(97)70220-2. J Am Acad Dermatol. 1997. PMID: 9216532 Review.
-
Kaposi's sarcoma and its associated herpesvirus.Nat Rev Cancer. 2010 Oct;10(10):707-19. doi: 10.1038/nrc2888. Nat Rev Cancer. 2010. PMID: 20865011 Free PMC article. Review.
Cited by
-
Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8 clustering in Kaposi's sarcoma and non-Kaposi's cases.J Exp Clin Cancer Res. 2015 Jan 16;34(1):1. doi: 10.1186/s13046-014-0119-0. J Exp Clin Cancer Res. 2015. PMID: 25592960 Free PMC article.
-
Association between Kaposi's sarcoma-associated herpesvirus genotype and clinical types.Pathol Oncol Res. 2025 Apr 28;31:1612009. doi: 10.3389/pore.2025.1612009. eCollection 2025. Pathol Oncol Res. 2025. PMID: 40356617 Free PMC article.
-
Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies.Clin Dermatol. 2013 Jul-Aug;31(4):413-422. doi: 10.1016/j.clindermatol.2013.01.008. Clin Dermatol. 2013. PMID: 23806158 Free PMC article. Review.
-
Genotypic distribution of HHV-8 in AIDS individuals without and with Kaposi sarcoma: Is genotype B associated with better prognosis of AIDS-KS?Medicine (Baltimore). 2016 Nov;95(48):e5291. doi: 10.1097/MD.0000000000005291. Medicine (Baltimore). 2016. PMID: 27902590 Free PMC article.
-
View and review on viral oncology research.Infect Agent Cancer. 2010 May 24;5:11. doi: 10.1186/1750-9378-5-11. Infect Agent Cancer. 2010. PMID: 20497566 Free PMC article.
References
-
- Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis. 2000;181(5):1562–8. - PubMed
-
- Boldorini R, Pagani E, Car PG, Omodeo-Zorini E, Borghi E, Tarantini L, Bellotti C, Ferrante P, Monga G. Molecular characterization of JCV virus strains detected in human brain tumors. Pathology. 2003;35:248–253. - PubMed
-
- Boneschi V, Brambilla L, Berti E, Ferrucci S, Corbellino M, Parravicini C, Fossati S. Human herpesvirus 8 DNA in the skin and blood of patients with Mediterranean Kaposi’s sarcoma: clinical correlations. Dermatology. 2001;203(1):19–23. - PubMed
-
- Boralevi F, Masquelier B, Denayrolles M, Dupon M, Pellegrin JL, Ragnaud JM, Fleury HJ. Study of human herpesvirus 8 (HHV-8) variants from Kaposi’s sarcoma in France: is HHV-8 subtype A responsible for more agressive tumors? J Infect Dis. 1998;178(5):1546–7. - PubMed
-
- Brambilla L, Boneschi V, Taglioni M, Ferrucci S. Staging of classic Kaposi’s sarcoma: a useful tool for therapeutic choices. Eur J Dermatol. 2003;13(1):83–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical